Skip to content
10-Q

Quarterly Report

BIOLASE, INC.

0000950170-24-123472

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 31, 2024 36.6M sh
Shares Diluted Q3 2024 · Sep 30, 2024 36.08M sh
Shares Diluted Q3 2024 · Sep 30, 2024 29.13M sh
Shares Diluted Q3 2024 · Sep 30, 2023 1.18M sh
Shares Diluted Q3 2024 · Sep 30, 2023 687K sh
Capex Q3 2024 · Sep 30, 2024 $67K
Capex Q3 2024 · Sep 30, 2023 $1.13M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$11.14M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$11.81M
Long Term Debt Q3 2024 · Sep 30, 2024 $0
Long Term Debt Q3 2024 · Dec 31, 2023 $11.78M
Short Term Debt Q3 2024 · Sep 30, 2024 $16.04M
Short Term Debt Q3 2024 · Dec 31, 2023 $2.27M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $3.44M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $6.57M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$5.23M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$4.33M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$247K
Stockholders Equity Q3 2024 · Sep 30, 2023 $332K
Stockholders Equity Q3 2024 · Jun 30, 2023 $6.62M
Stockholders Equity Q3 2024 · Dec 31, 2022 $4.89M
Current Liabilities Q3 2024 · Sep 30, 2024 $30.86M
Current Liabilities Q3 2024 · Dec 31, 2023 $19.66M
Total Liabilities Q3 2024 · Sep 30, 2024 $32.12M
Total Liabilities Q3 2024 · Dec 31, 2023 $33.15M
Current Assets Q3 2024 · Sep 30, 2024 $19.43M
Current Assets Q3 2024 · Dec 31, 2023 $24.86M
Total Assets Q3 2024 · Sep 30, 2024 $27.24M
Total Assets Q3 2024 · Dec 31, 2023 $35.1M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.04
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.37
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$10.35
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$47.01
Eps Basic Q3 2024 · Sep 30, 2024 −$0.04
Eps Basic Q3 2024 · Sep 30, 2024 −$0.37
Eps Basic restated Q3 2024 · Sep 30, 2023 −$10.35
Eps Basic restated Q3 2024 · Sep 30, 2023 −$47.01
Sga Expense Q3 2024 · Sep 30, 2024 $1.28M
Sga Expense Q3 2024 · Sep 30, 2024 $7.54M
Sga Expense Q3 2024 · Sep 30, 2023 $2.68M
Sga Expense Q3 2024 · Sep 30, 2023 $7.5M
Rd Expense Q3 2024 · Sep 30, 2024 $917K
Rd Expense Q3 2024 · Sep 30, 2024 $3.27M
Rd Expense Q3 2024 · Sep 30, 2023 $1.36M
Rd Expense Q3 2024 · Sep 30, 2023 $4.35M
Net Income Q3 2024 · Sep 30, 2024 −$1.43M
Net Income Q3 2024 · Sep 30, 2024 −$10.71M
Net Income Q3 2024 · Sep 30, 2023 −$4.59M
Net Income Q3 2024 · Sep 30, 2023 −$15.31M
Operating Income Q3 2024 · Sep 30, 2024 −$695K
Operating Income Q3 2024 · Sep 30, 2024 −$8.44M
Operating Income Q3 2024 · Sep 30, 2023 −$3.7M
Operating Income Q3 2024 · Sep 30, 2023 −$12.86M
Gross Profit Q3 2024 · Sep 30, 2024 $4.38M
Gross Profit Q3 2024 · Sep 30, 2024 $12.33M
Gross Profit Q3 2024 · Sep 30, 2023 $3.75M
Gross Profit Q3 2024 · Sep 30, 2023 $13.2M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $6.47M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $20.21M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $7.18M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $22.47M
Revenue Q3 2024 · Sep 30, 2024 $10.85M
Revenue Q3 2024 · Sep 30, 2024 $32.54M
Revenue Q3 2024 · Sep 30, 2023 $10.92M
Revenue Q3 2024 · Sep 30, 2023 $35.67M